<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Treatment of delusional infestation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Treatment of delusional infestation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Treatment of delusional infestation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kathryn N Suh, MD, FRCPC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen Marder, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Erik Stratman, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael Friedman, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Abena O Ofori, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 02, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H521793394">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Delusional infestation is a rare disorder in which affected individuals have the fixed, false belief (delusion) that they are infected by "bugs": parasites, worms, bacteria, fungi, mites, or other living organisms, or “fibers.” As with all delusions, this belief cannot be corrected by reasoning, persuasion, or logical argument. Many affected individuals are quite functional; for the minority, delusions of parasitic infection may interfere with usual activities, and for some very significantly [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Delusions of infestation are the most common form of monosymptomatic hypochondriacal psychosis; others include delusions of dysmorphism and delusions of body odor or halitosis.
        </p>
        <p>
         This topic addresses the treatment of delusional infestation. The epidemiology, clinical presentation, and diagnosis of delusional infestation are discussed separately. Other psychotic disorders are discussed separately. First- and second-generation antipsychotic medications are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6957.html" rel="external">
          "Delusional infestation: Epidemiology, clinical presentation, assessment, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/6956.html" rel="external">
          "Postpartum psychosis: Epidemiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14773.html" rel="external">
          "First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14776.html" rel="external">
          "Second-generation antipsychotic medications: Pharmacology, administration, and side effects"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14805.html" rel="external">
          "Schizophrenia in adults: Maintenance therapy and side effect management"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H521793401">
         <span class="h1">
          TERMINOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Delusional infestation is also called delusional parasitosis [
         <a href="#rid2">
          2
         </a>
         ]. It is a delusional disorder of the somatic type [
         <a href="#rid3">
          3
         </a>
         ], a subgroup of delusional disorders in which nonexistent disease or alteration of the body forms the basis of the disorder.
        </p>
        <p>
         Two forms of delusional infestation are widely recognized [
         <a href="#rid4">
          4,5
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Primary delusional infestation
         </strong>
         – Primary delusional infestation is a psychiatric disorder with the delusion of parasitic infection as its only manifestation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Secondary delusional infestation
         </strong>
         – Secondary delusional infestation is a symptom rather than a disorder. The delusion of infestation occurs secondary to another psychiatric disorder or to a medical illness.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12625559">
         <span class="h1">
          APPROACH TO THE PATIENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         Key to the management of patients with delusional infestation is the development of a strong, therapeutic relationship. Many patients express dissatisfaction with previous clinicians whom they believe are incompetent and uncaring. As a result, patients often fail to attend follow-up appointments and receive inadequate or no therapy. A nonjudgmental approach, acknowledgment that the patient's symptoms are real, and empathetic exploration into the effects their symptoms have had on their daily lives can instill a sense of trust [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         It has been debated whether or not the clinician should overtly agree or disagree with the patient's beliefs [
         <a href="#rid7">
          7
         </a>
         ]. Many authors suggest that a nonconfrontational approach be employed [
         <a href="#rid1">
          1,7-9
         </a>
         ], using phrases such as "I cannot see any parasites today" rather than "there are no parasites" [
         <a href="#rid10">
          10
         </a>
         ], and acknowledging that a problem may have resulted from a previous infection [
         <a href="#rid11">
          11
         </a>
         ]. In our clinical experience, it is important to neither dismiss patients’ complaints as trivial nor to overtly support unfounded beliefs and feed into their delusional system. Reassurance that the patient can be helped can be worthwhile.
        </p>
        <p>
         Convincing patients to take antipsychotic medications is a major challenge in the management of this disorder. Rejection of a psychiatric basis for the dermopathy is a defining characteristic of the illness, thus rejection of psychiatric treatment is to be expected. A number of strategies has been suggested in prescribing antipsychotics for these patients.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         One strategy is to tell the patient that the problem is a "biochemical imbalance," possibly the result of a previous infection that is no longer present. Patients may be more likely to agree to take medication for treatment of a "chemical imbalance" than for a psychiatric problem.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It should be explained to the patient that although antipsychotic medications are commonly used for schizophrenia, it is not being used for schizophrenia and the patient does not have the disorder.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It can be further explained to the patient that drugs used for one purpose are often found to have additional unrelated uses. It is important to provide examples, such as
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         for pyrexia and stroke prevention, beta blockers for coronary artery disease and prevention of migraine headaches, or
         <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">
          amitriptyline
         </a>
         for depression and neuritis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some patients may be persuaded to try medication when told that other patients with a similar condition have experienced great relief in their symptoms.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients who ask why they continue to "see" parasites when others do not, the concept of the "phantom limb" may be presented as a possible explanation.
        </p>
        <p>
        </p>
        <p>
         Some clinicians recommend bypassing the disclosure of a delusional diagnosis to patients who are likely to respond by refusing the antipsychotic, thus protecting them from harm. This approach is controversial, and raises concerns about withholding information based on principles of patient autonomy and informed consent [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p>
         In the case of initial adverse drug events or failure of an antipsychotic medication, it is helpful to explain to the patient that it is important to find the “right drug for the right patient,” one that is both safe and effective. This explanation may help allay the patient’s concerns or impatience when more than one drug regimen is necessary.
        </p>
        <p class="headingAnchor" id="H12625566">
         <span class="h1">
          PHARMACOTHERAPY
         </span>
        </p>
        <p class="headingAnchor" id="H352928002">
         <span class="h2">
          Choosing initial medication
         </span>
         <span class="headingEndMark">
          —
         </span>
         Our preference for first-line treatment of primary delusional infestation is with second-generation antipsychotic medications rather than first-generation antipsychotics or other medications. Antipsychotics vary widely in their side effect profiles. We favor second-generation antipsychotics rather than first-generation antipsychotics based on their lower rate of extrapyramidal symptoms. Side effects of antipsychotics are presented on the associated table  (
         <a class="graphic graphic_table graphicRef82533" href="/z/d/graphic/82533.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Monitoring and side effects'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/14776.html" rel="external">
          "Second-generation antipsychotic medications: Pharmacology, administration, and side effects"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14773.html" rel="external">
          "First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects"
         </a>
         .)
        </p>
        <p>
         In the absence of evidence to support one particular antipsychotic over another, our preference among second-generation antipsychotics is
         <a class="drug drug_general" data-topicid="9868" href="/z/d/drug information/9868.html" rel="external">
          risperidone
         </a>
         as it has been most widely studied [
         <a href="#rid14">
          14,15
         </a>
         ]. However, we consider specific patient factors such medical history (eg, cardiovascular risk factors), history of prior treatment with antipsychotic medication, weight, and patient preference. Discussion of choice of antipsychotic in specific populations is found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/130944.html" rel="external">
          "Psychosis in adults: Initial management", section on 'Additional patient-specific considerations'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9773" href="/z/d/drug information/9773.html" rel="external">
          Pimozide
         </a>
         , a first-generation antipsychotic that has been widely used in practice and published reports for delusional infestation [
         <a href="#rid10">
          10,16-19
         </a>
         ], is no longer considered first-line treatment. Pimozide has antagonistic effects on opiate receptors in addition to a selective blockade of dopamine type 2 receptors. The opioid blockade has been postulated as contributing to a reduction in pruritus and formication [
         <a href="#rid20">
          20,21
         </a>
         ]. However, there is no rigorous evidence that pimozide is more effective in treating delusion infestation than other antipsychotic medications [
         <a href="#rid21">
          21,22
         </a>
         ]. In addition, pimozide’s side effect profile has disadvantages compared with other antipsychotics (eg, prolonged QT interval). (See
         <a class="local">
          'Monitoring and side effects'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/130944.html" rel="external">
          "Psychosis in adults: Initial management", section on 'Cardiovascular risk factors'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H341822342">
         <span class="h2">
          Initiating and titrating antipsychotic medication
         </span>
         <span class="headingEndMark">
          —
         </span>
         We prefer to initiate the antipsychotic at a low dose and increase gradually (eg, in weekly increments) to minimize side effects and arrive at the lowest effective daily dose. Patients with delusional infestation often respond to antipsychotic medications at lower doses than patients with other psychotic disorders.
        </p>
        <p>
         As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We begin
         <a class="drug drug_general" data-topicid="9868" href="/z/d/drug information/9868.html" rel="external">
          risperidone
         </a>
         at 0.5 mg/day (given as one or two daily doses) and advanced weekly to the lowest clinically effective dose [
         <a href="#rid23">
          23-25
         </a>
         ]. In our experience, most patients require between 2 and 4 mg/day; however, when necessary, the dose can be increased up to 8 mg/day.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We begin
         <a class="drug drug_general" data-topicid="8786" href="/z/d/drug information/8786.html" rel="external">
          aripiprazole
         </a>
         at 2 mg/day and increase by 2 mg every two weeks; typical dose 8 to 12 mg/day.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We begin
         <a class="drug drug_general" data-topicid="9716" href="/z/d/drug information/9716.html" rel="external">
          olanzapine
         </a>
         at 2.5 mg/day and titrate by 2.5 mg every week. Typical dose needed is between 2.5 to 7.5 mg/day; however, doses up to 20 mg/day may be necessary in some patients for an optimal response [
         <a href="#rid26">
          26-28
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We begin
         <a class="drug drug_general" data-topicid="9570" href="/z/d/drug information/9570.html" rel="external">
          quetiapine
         </a>
         at 25 to 50 mg and titrate by 25 to 50 mg weekly to 200 mg/day if needed.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3461830604">
         <span class="h2">
          Monitoring and side effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prior to beginning treatment with antipsychotic medications (ie, first- or second-generation), we obtain a baseline metabolic panel and an electrocardiogram (ECG). We avoid medications that are associated with prolonged QT interval in individuals prolonged baseline QT interval. (See
         <a class="medical medical_review" href="/z/d/html/1043.html" rel="external">
          "Acquired long QT syndrome: Definitions, pathophysiology, and causes"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/116011.html" rel="external">
          "Acquired long QT syndrome: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p>
         Adverse effects associated with first- and second-generation antipsychotics are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/14773.html" rel="external">
          "First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14776.html" rel="external">
          "Second-generation antipsychotic medications: Pharmacology, administration, and side effects"
         </a>
         .)
        </p>
        <p>
         A table provides a recommended schedule for monitoring the metabolic effects of first- and second-generation antipsychotics  (
         <a class="graphic graphic_table graphicRef74435" href="/z/d/graphic/74435.html" rel="external">
          table 2
         </a>
         ). More frequent measurements may be necessary for individual patients (eg, more frequent assessment of lipids and glucose in the patient who has a significant weight gain) or for patients on specific antipsychotics (eg,
         <a class="drug drug_general" data-topicid="9716" href="/z/d/drug information/9716.html" rel="external">
          olanzapine
         </a>
         and
         <a class="drug drug_general" data-topicid="9570" href="/z/d/drug information/9570.html" rel="external">
          quetiapine
         </a>
         ), where there is clear evidence of an increased risk of insulin resistance [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3884194551">
         <span class="h2">
          Efficacy
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are no randomized clinical trials of antipsychotic medication for primary delusional infestation [
         <a href="#rid14">
          14,20,30
         </a>
         ]. A systematic review of case series and observational studies including almost 300 patients found response rates to antipsychotics of 60 to 100 percent [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p>
         In analyses of published outcomes of treated cases of delusional infestation, no particular antipsychotic agent appears clearly superior to others, nor is there a difference in response rates between first- and second-generation antipsychotics.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         First-generation antipsychotics described in published cases as effectively treating delusional infestation include
         <a class="drug drug_general" data-topicid="9773" href="/z/d/drug information/9773.html" rel="external">
          pimozide
         </a>
         [
         <a href="#rid10">
          10,16-19
         </a>
         ],
         <a class="drug drug_general" data-topicid="9760" href="/z/d/drug information/9760.html" rel="external">
          perphenazine
         </a>
         [
         <a href="#rid31">
          31
         </a>
         ],
         <a class="drug drug_general" data-topicid="9252" href="/z/d/drug information/9252.html" rel="external">
          chlorpromazine
         </a>
         [
         <a href="#rid32">
          32
         </a>
         ],
         <a class="drug drug_general" data-topicid="9991" href="/z/d/drug information/9991.html" rel="external">
          thioridazine
         </a>
         [
         <a href="#rid33">
          33
         </a>
         ],
         <a class="drug drug_general" data-topicid="10020" href="/z/d/drug information/10020.html" rel="external">
          trifluoperazine
         </a>
         ,
         <a class="drug drug_general" data-topicid="8516" href="/z/d/drug information/8516.html" rel="external">
          haloperidol
         </a>
         , and
         <a class="drug drug_general" data-topicid="8467" href="/z/d/drug information/8467.html" rel="external">
          fluphenazine
         </a>
         [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Second-generation antipsychotics described in case reports and case series as effectively treating delusional infestation include
         <a class="drug drug_general" data-topicid="9868" href="/z/d/drug information/9868.html" rel="external">
          risperidone
         </a>
         [
         <a href="#rid23">
          23-25,34
         </a>
         ],
         <a class="drug drug_general" data-topicid="9716" href="/z/d/drug information/9716.html" rel="external">
          olanzapine
         </a>
         [
         <a href="#rid35">
          35-38
         </a>
         ],
         <a class="drug drug_general" data-topicid="9570" href="/z/d/drug information/9570.html" rel="external">
          quetiapine
         </a>
         [
         <a href="#rid34">
          34
         </a>
         ], sertindole [
         <a href="#rid39">
          39
         </a>
         ], sulpiride [
         <a href="#rid40">
          40
         </a>
         ],
         <a class="drug drug_general" data-topicid="8786" href="/z/d/drug information/8786.html" rel="external">
          aripiprazole
         </a>
         [
         <a href="#rid41">
          41
         </a>
         ],
         <a class="drug drug_general" data-topicid="10174" href="/z/d/drug information/10174.html" rel="external">
          paliperidone
         </a>
         [
         <a href="#rid39">
          39
         </a>
         ], and
         <a class="drug drug_general" data-topicid="10040" href="/z/d/drug information/10040.html" rel="external">
          ziprasidone
         </a>
         [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Randomized clinical trials have demonstrated the efficacy of antipsychotics in reducing psychosis in a variety of psychotic disorders [
         <a href="#rid43">
          43-45
         </a>
         ], without consistent differences in efficacy among the medications. (See
         <a class="medical medical_review" href="/z/d/html/679.html" rel="external">
          "Bipolar mania and hypomania in adults: Choosing pharmacotherapy", section on 'Initial treatment'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16546.html" rel="external">
          "Unipolar major depression with psychotic features: Acute treatment", section on 'Treatment'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/130944.html" rel="external">
          "Psychosis in adults: Initial management", section on 'Antipsychotic therapy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4288830260">
         <span class="h1">
          SUBSEQUENT TREATMENT
         </span>
        </p>
        <p class="headingAnchor" id="H409748994">
         <span class="h2">
          Good response to antipsychotic
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no clearly established optimal duration of pharmacologic treatment after achieving an adequate clinical response. Our preference is to maintain the antipsychotic at the therapeutic dose for several months, and up to one year. Some experts suggest treatment for at least one year after response [
         <a href="#rid15">
          15,40,46
         </a>
         ].
        </p>
        <p>
         When discontinued, the medication should be tapered gradually over a period of weeks [
         <a href="#rid40">
          40,46
         </a>
         ]. If relapse occurs, patients often respond to reinstitution of the medication. Relapses are common though the exact rate is not known [
         <a href="#rid10">
          10
         </a>
         ]. Some patients require prolonged therapy to avoid relapse.
        </p>
        <p class="headingAnchor" id="H3198029973">
         <span class="h2">
          Poor response to antipsychotic
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adjustments to antipsychotic treatment in cases of poor response are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/14805.html" rel="external">
          "Schizophrenia in adults: Maintenance therapy and side effect management", section on 'Medication adjustments'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1505551686">
         <span class="h1">
          SECONDARY DELUSIONAL INFESTATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment of a secondary delusional infestation should focus on the primary medical illness or psychiatric disorder. Antipsychotic medications are sometimes used symptomatically for limited periods, but play a minor role in treatment unless indicated for treatment of the primary illness. (See
         <a class="medical medical_review" href="/z/d/html/6957.html" rel="external">
          "Delusional infestation: Epidemiology, clinical presentation, assessment, and diagnosis", section on 'Secondary delusional infestation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14773.html" rel="external">
          "First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14776.html" rel="external">
          "Second-generation antipsychotic medications: Pharmacology, administration, and side effects"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H500468915">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/117525.html" rel="external">
          "Society guideline links: Psychotic disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12626396">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Delusional infestation (also called delusional parasitosis)
         </strong>
         is a rare disorder in which affected individuals have the fixed, false belief (delusion) that they are infected by “bugs”: parasites, worms, bacteria, fungi, mites, or other living organisms, or “fibers.” (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Terminology
         </strong>
         – Two forms of delusional infestation are widely recognized. (See
         <a class="local">
          'Terminology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Primary delusional infestation
         </strong>
         is a psychiatric disorder with the delusion of parasitic infection as its only manifestation. It is a diagnosis of exclusion after ruling out a parasitic infection and other medical and psychiatric illnesses. (See
         <a class="medical medical_review" href="/z/d/html/6957.html" rel="external">
          "Delusional infestation: Epidemiology, clinical presentation, assessment, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Secondary delusional infestation
         </strong>
         is a symptom of another psychiatric or medical illness rather than a disorder. Treatment is generally focused on the primary disorder. (See
         <a class="medical medical_review" href="/z/d/html/6957.html" rel="external">
          "Delusional infestation: Epidemiology, clinical presentation, assessment, and diagnosis", section on 'Secondary delusional infestation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Approach to the patient
         </strong>
         – Patients with delusional infestation typically present in primary care or to a dermatologist. They usually are highly resistant to the idea of assessment by a psychiatrist. Whether in general medical care or psychiatric care, the development of a strong, therapeutic relationship instilling trust is central to clinical management.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Convincing patients to take antipsychotic medications is a major challenge in the management of this disorder. Rejection of a psychiatric basis for the dermopathy is a defining characteristic of the illness. (See
         <a class="local">
          'Approach to the patient'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Choosing initial pharmacotherapy
         </strong>
         – For patients with primary delusional infestation, we recommend treatment with an antipsychotic medication (
         <a class="grade" href="https:///uptodate/show/grade_2" rel="external">
          Grade 1B
         </a>
         ). Antipsychotic medications are associated with high treatment response rate; other therapies have not been systematically evaluated. (See
         <a class="local">
          'Pharmacotherapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In the absence of evidence to support one particular antipsychotic over another, our preference among second-generation antipsychotics is
         <a class="drug drug_general" data-topicid="9868" href="/z/d/drug information/9868.html" rel="external">
          risperidone
         </a>
         as it has been most widely studied. We consider specific patient factors such medical history (eg, cardiovascular risk factors), history of prior treatment with antipsychotic medication, weight, and patient preference. Side effects of antipsychotics are found on the table  (
         <a class="graphic graphic_table graphicRef82533" href="/z/d/graphic/82533.html" rel="external">
          table 1
         </a>
         ). (See
         <a class="local">
          'Pharmacotherapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initiating and titrating medication
         </strong>
         – Patients with delusional infestation often respond to antipsychotic medications at lower doses than patients with other psychotic disorders. We initiate the antipsychotic at a low dose and increase gradually in weekly increments in order to minimize side effects and arrive at the lowest effective daily dose. (See
         <a class="local">
          'Initiating and titrating antipsychotic medication'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Subsequent treatment
         </strong>
         – After achieving an adequate clinical response, our preference is to maintain the antipsychotic for several months or up to one year. Some experts suggest treatment for at least one year after response. (See
         <a class="local">
          'Good response to antipsychotic'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3574527491">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Jay Keystone, MD, MSc (CTM), FRCPC (deceased), who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Lynch PJ. Delusions of parasitosis. Semin Dermatol 1993; 12:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bewley AP, Lepping P, Freudenmann RW, Taylor R. Delusional parasitosis: time to call it delusional infestation. Br J Dermatol 2010; 163:1.
          </a>
         </li>
         <li class="breakAll">
          American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, 2013.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Musalek M, Bach M, Passweg V, Jaeger S. The position of delusional parasitosis in psychiatric nosology and classification. Psychopathology 1990; 23:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freinhar JP. Delusions of parasitosis. Psychosomatics 1984; 25:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gould WM, Gragg TM. Delusions of parasitosis. An approach to the problem. Arch Dermatol 1976; 112:1745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wykoff RF. Delusions of parasitosis: a review. Rev Infect Dis 1987; 9:433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aw DC, Thong JY, Chan HL. Delusional parasitosis: case series of 8 patients and review of the literature. Ann Acad Med Singapore 2004; 33:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winsten M. Delusional parasitosis: a practical guide for the family practitioner in evaluation and treatment strategies. J Am Osteopath Assoc 1997; 97:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lyell A. The Michelson Lecture. Delusions of parasitosis. Br J Dermatol 1983; 108:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zanol K, Slaughter J, Hall R. An approach to the treatment of psychogenic parasitosis. Int J Dermatol 1998; 37:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bostick NA, Sade R, McMahon JW, et al. Report of the American Medical Association Council on Ethical and Judicial Affairs: withholding information from patients: rethinking the propriety of "therapeutic privilege". J Clin Ethics 2006; 17:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwin A. Don't Lie but Don't Tell the Whole Truth: The Therapeutic Privilege - Is it Ever Justified? Ghana Med J 2008; 42:156.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McPhie ML, Kirchhof MG. A systematic review of antipsychotic agents for primary delusional infestation. J Dermatolog Treat 2022; 33:709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ahmed A, Affleck AG, Angus J, et al. British Association of Dermatologists guidelines for the management of adults with delusional infestation 2022. Br J Dermatol 2022; 187:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trabert W. 100 years of delusional parasitosis. Meta-analysis of 1,223 case reports. Psychopathology 1995; 28:238.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatia MS, Jagawat T, Choudhary S. Delusional parasitosis: a clinical profile. Int J Psychiatry Med 2000; 30:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reilly TM, Batchelor DH. The presentation and treatment of delusional parasitosis: a dermatological perspective. Int Clin Psychopharmacol 1986; 1:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zomer SF, De Wit RF, Van Bronswijk JE, et al. Delusions of parasitosis. A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. Br J Dermatol 1998; 138:1030.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lepping P, Russell I, Freudenmann RW. Antipsychotic treatment of primary delusional parasitosis: systematic review. Br J Psychiatry 2007; 191:198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ungvári G, Vladár K. Pimozide treatment for delusion of infestation. Act Nerv Super (Praha) 1986; 28:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamann K, Avnstorp C. Delusions of infestation treated by pimozide: a double-blind crossover clinical study. Acta Derm Venereol 1982; 62:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           De León OA, Furmaga KM, Canterbury AL, Bailey LG. Risperidone in the treatment of delusions of infestation. Int J Psychiatry Med 1997; 27:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Safer DL, Wenegrat B, Roth WT. Risperidone in the treatment of delusional parasitosis: a case report. J Clin Psychopharmacol 1997; 17:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wenning MT, Davy LE, Catalano G, Catalano MC. Atypical antipsychotics in the treatment of delusional parasitosis. Ann Clin Psychiatry 2003; 15:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freudenmann RW, Lepping P. Second-generation antipsychotics in primary and secondary delusional parasitosis: outcome and efficacy. J Clin Psychopharmacol 2008; 28:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heller MM, Wong JW, Lee ES, et al. Delusional infestations: clinical presentation, diagnosis and treatment. Int J Dermatol 2013; 52:775.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kenchaiah BK, Kumar S, Tharyan P. Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients. Int J Dermatol 2010; 49:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baptista T, Kin NM, Beaulieu S, de Baptista EA. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Pharmacopsychiatry 2002; 35:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manschreck TC, Khan NL. Recent advances in the treatment of delusional disorder. Can J Psychiatry 2006; 51:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           May WW, Terpenning MS. Delusional parasitosis in geriatric patients. Psychosomatics 1991; 32:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Srinivasan TN, Suresh TR, Jayaram V, Fernandez MP. Nature and treatment of delusional parasitosis: a different experience in India. Int J Dermatol 1994; 33:851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freyne A, Wrigley M. Delusional infestation in an elderly population. Ir Med J 1994; 87:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gallucci G, Beard G. Risperidone and the treatment of delusions of parasitosis in an elderly patient. Psychosomatics 1995; 36:578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakaya M. Olanzapine treatment of monosymptomatic hypochondriacal psychosis. Gen Hosp Psychiatry 2004; 26:166.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freudenmann RW. [A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy]. Nervenarzt 2003; 74:591.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meehan WJ, Badreshia S, Mackley CL. Successful treatment of delusions of parasitosis with olanzapine. Arch Dermatol 2006; 142:352.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freudenmann RW, Schönfeldt-Lecuona C, Lepping P. Primary delusional parasitosis treated with olanzapine. Int Psychogeriatr 2007; 19:1161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freudenmann RW, Kühnlein P, Lepping P, Schönfeldt-Lecuona C. Secondary delusional parasitosis treated with paliperidone. Clin Exp Dermatol 2009; 34:375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koo J, Gambla C. Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis. General discussion and case illustrations. Dermatol Clin 1996; 14:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rocha FL, Hara C. Aripiprazole in delusional parasitosis: Case report. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Contreras-Ferrer P, de Paz NM, Cejas-Mendez MR, et al. Ziprasidone in the treatment of delusional parasitosis. Case Rep Dermatol 2012; 4:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghaemi SN, Goodwin FK. Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature. J Clin Psychopharmacol 1999; 19:354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wijkstra J, Lijmer J, Balk FJ, et al. Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis. Br J Psychiatry 2006; 188:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith LA, Cornelius V, Warnock A, et al. Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. Bipolar Disord 2007; 9:551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Driscoll MS, Rothe MJ, Grant-Kels JM, Hale MS. Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach. J Am Acad Dermatol 1993; 29:1023.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 15747 Version 23.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8476732" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Delusions of parasitosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20645978" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Delusional parasitosis: time to call it delusional infestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20645978" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Delusional parasitosis: time to call it delusional infestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2259708" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The position of delusional parasitosis in psychiatric nosology and classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6701279" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Delusions of parasitosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1008566" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Delusions of parasitosis. An approach to the problem.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3299633" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Delusions of parasitosis: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15008571" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Delusional parasitosis: case series of 8 patients and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9059004" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Delusional parasitosis: a practical guide for the family practitioner in evaluation and treatment strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6838775" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The Michelson Lecture. Delusions of parasitosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9522244" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : An approach to the treatment of psychogenic parasitosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17330719" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Report of the American Medical Association Council on Ethical and Judicial Affairs: withholding information from patients: rethinking the propriety of "therapeutic privilege".
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19452024" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Don't Lie but Don't Tell the Whole Truth: The Therapeutic Privilege - Is it Ever Justified?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32658556" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : A systematic review of antipsychotic agents for primary delusional infestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35582951" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : British Association of Dermatologists guidelines for the management of adults with delusional infestation 2022.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8559947" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : 100 years of delusional parasitosis. Meta-analysis of 1,223 case reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10900563" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Delusional parasitosis: a clinical profile.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3559158" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : The presentation and treatment of delusional parasitosis: a dermatological perspective.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9747367" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Delusions of parasitosis. A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17766758" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Antipsychotic treatment of primary delusional parasitosis: systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3739562" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Pimozide treatment for delusion of infestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6175138" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Delusions of infestation treated by pimozide: a double-blind crossover clinical study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9565735" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Risperidone in the treatment of delusions of infestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10950485" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Risperidone in the treatment of delusional parasitosis: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14971869" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Atypical antipsychotics in the treatment of delusional parasitosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18794644" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Second-generation antipsychotics in primary and secondary delusional parasitosis: outcome and efficacy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23789596" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Delusional infestations: clinical presentation, diagnosis and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20465623" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12518268" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16989110" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Recent advances in the treatment of delusional disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2003143" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Delusional parasitosis in geriatric patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7883408" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Nature and treatment of delusional parasitosis: a different experience in India.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8056548" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Delusional infestation in an elderly population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7501790" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Risperidone and the treatment of delusions of parasitosis in an elderly patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15038937" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Olanzapine treatment of monosymptomatic hypochondriacal psychosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12861369" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : [A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16549712" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Successful treatment of delusions of parasitosis with olanzapine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17397562" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Primary delusional parasitosis treated with olanzapine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19040517" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Secondary delusional parasitosis treated with paliperidone.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8818552" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Delusions of parasitosis and other forms of monosymptomatic hypochondriacal psychosis. General discussion and case illustrations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17289238" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Aripiprazole in delusional parasitosis: Case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22807899" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Ziprasidone in the treatment of delusional parasitosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10440464" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Use of atypical antipsychotic agents in bipolar and schizoaffective disorders: review of the empirical literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16648526" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17845269" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7902366" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
